Carcinoma erysipeloides from ovarian clear-cell carcinoma.
Lee
Hsing-Chuan
HC
Department of Dermatology, National Taiwan University Hospital, Taipei, Taiwan.
Chu
Chia-Yu
CY
Hsiao
Cheng-Hsiang
CH
D018262:Adenocarcinoma, Clear Cell / Q000175:diagnosis / Q000556:secondary* / Q000628:therapy; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D016190:Carboplatin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D013509:Gynecologic Surgical Procedures; D006801:Humans; D035002:Lower Extremity; D008175:Lung Neoplasms / Q000556:secondary* / Q000628:therapy; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis; D010051:Ovarian Neoplasms / Q000175:diagnosis / Q000473:pathology* / Q000628:therapy; D017239:Paclitaxel / Q000008:administration & dosage; D012878:Skin Neoplasms / Q000188:drug therapy / Q000556:secondary*
D003520:Cyclophosphamide; D016190:Carboplatin; D017239:Paclitaxel